Stock Comparison

CYTK vs REGN

Cytokinetics Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

CYTK

Cytokinetics Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$11.16B

$66.35B

P/E (TTM)

—

15.5

Forward P/E

117.7

14.1

Price/Sales

105.5

4.5

Price/Book

60.3

2.1

EV/EBITDA

-15.8

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

0.00%

29.60%

Operating Margin

-949.00%

20.70%

Return on Equity

-572.00%

14.50%

Return on Assets

-31.50%

6.13%

Growth (YoY)

Revenue Growth

1126.00%

19.00%

Earnings Growth

0.00%

-7.20%

Price & Risk

Beta

0.4

0.2

52-Week High

$84.55

$818.90

52-Week Low

$32.66

$516.07

Analyst Target

$105.60

$833.31

Compare CYTK and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.